Results 41 to 50 of about 230,179 (340)

MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2019
Significance Bacterial toxins belonging to the family of superantigens are potent immunostimulatory antigens capable of activating T cells in a nonconventional manner.
Johanna E. M. Emgård   +6 more
semanticscholar   +1 more source

The Association Between Onset of Staphylococcal Non-menstrual Toxic Shock Syndrome With Inducibility of Toxic Shock Syndrome Toxin-1 Production

open access: yesFrontiers in Microbiology, 2022
Non-menstrual toxic shock syndrome (non-mTSS) is a life-threatening disease caused by Staphylococcus aureus strains producing superantigens, such as staphylococcal enterotoxins A, B, C, and toxic shock syndrome toxin-1 (TSST-1).
Yusuke Taki   +18 more
doaj   +1 more source

Detection of Toxic Shock Syndrome Toxin-1 among Children Undergoing Surgical Operations

open access: yesمجلة كلية الطب, 2017
Background: Toxic-shock syndrome (TSS) is an acute onset; multiorgan disease caused mainly by Toxic-shock syndrome toxin-1 (TSST-1) producing Staphylococcus aureus strains.Testing for TSST-1 or anti-TSST-1 antibodies in the clinical setting may help to ...
Abdul-Razak Sh. Hasan   +2 more
doaj   +1 more source

Streptococcal toxic shock syndrome in an adolescent

open access: yesМедицинский совет, 2022
A  special form of  streptococcal infection is streptococcal toxic shock syndrome  (STS), characterized by rapid development of symptoms and high mortality. Patient O., 14 years old, was taken to the infectious diseases department of OGAUZ DBNo. 1 by the
N. A. Ryzhakova   +8 more
doaj   +1 more source

Regulation of toxic shock syndrome toxin‐1 by the accessory gene regulator in Staphylococcus aureus is mediated by the repressor of toxins

open access: yesMolecular Microbiology, 2019
Toxic shock syndrome toxin‐1 (TSST‐1) is a superantigen (SAg) produced by Staphylococcus aureus thought to be responsible for essentially all cases of menstrual‐associated toxic shock syndrome (TSS).
S. Tuffs   +6 more
semanticscholar   +1 more source

Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited

open access: yesEmerging Infectious Diseases, 2017
Gene mutations in the virulence regulator CovR/S of group A Streptococcus play a substantial role in the pathogenesis of streptococcal toxic shock syndrome.
Parham Sendi   +3 more
doaj   +1 more source

Enterococcus faecalis inhibits superantigen toxic shock syndrome toxin-1-induced interleukin-8 from human vaginal epithelial cells through tetramic acids. [PDF]

open access: yesPLoS ONE, 2013
The vaginal mucosa can be colonized by many bacteria including commensal organisms and potential pathogens, such as Staphylococcus aureus. Some strains of S.
Amanda J Brosnahan   +4 more
doaj   +1 more source

An NLRP3 inflammasome-triggered cytokine storm contributes to Streptococcal toxic shock-like syndrome (STSLS)

open access: yesPLoS Pathogens, 2019
Infection with the Streptococcus suis (S. suis) epidemic strain can cause Streptococcal toxic shock-like syndrome (STSLS), which is characterized by a cytokine storm, dysfunction of multiple organs and a high incidence of mortality despite adequate ...
Lan Lin   +9 more
semanticscholar   +1 more source

Incomplete limb ischemia as a complication in a pediatric patient with toxic-shock syndrome

open access: yesJournal of Pediatric Surgery Case Reports, 2019
Toxic shock syndrome (TSS) is an acute, life-threatening rare pediatric disease associated with high mortality. Pathogens can be both staphylococci (especially S. aureus) and streptococci (group A streptococci).
Christina H. Wolfsberger   +5 more
doaj   +1 more source

Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]

open access: yes, 2020
Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth   +2 more
core  

Home - About - Disclaimer - Privacy